Greif Robert Smith 4
4 · H-CYTE, INC. · Filed Apr 5, 2021
Insider Transaction Report
Form 4
H-CYTE, INC.HCYT
Greif Robert Smith
President and C.E.O.
Transactions
- Award
Stock Option (right to buy)
2021-04-01+34,000,000→ 34,000,000 totalExercise: $0.07Exp: 2031-04-01→ Common Stock (34,000,000 underlying)
Footnotes (1)
- [F1]On April 1, 2021, Hy-Cyte, Inc. (the "Company) issued to Robert Greif options (the "Options") to purchase 34,000,000 shares of the Company's common stock at an exercise price of $0.07. The Options shall be exercisable with respect to 25% of the Option Shares on the six (6) month anniversary of the Date of Grant, and the remaining 75% of the Option Shares shall become exercisable in 12 equal quarterly installments thereafter on the final day of each fiscal quarter, in each case, so long as the Mr. Greif remains an employee of the Company or a subsidiary thereof on each such date